|
MYADM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25099999999756E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.024760E-04 |
| Normal-vs-Stage2 |
2.10599999994621E-06 |
| Normal-vs-Stage3 |
3.19749999999619E-06 |
| Normal-vs-Stage4 |
3.03160000003633E-06 |
| Stage1-vs-Stage2 |
2.670100E-02 |
| Stage1-vs-Stage3 |
3.463600E-02 |
| Stage1-vs-Stage4 |
3.714200E-02 |
| Stage2-vs-Stage3 |
6.064200E-01 |
| Stage2-vs-Stage4 |
7.137200E-01 |
| Stage3-vs-Stage4 |
8.901800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.01559999999779E-05 |
| Normal-vs-AfricanAmerican |
1.204100E-04 |
| Normal-vs-Asian |
1.818050E-04 |
| Caucasian-vs-AfricanAmerican |
8.428600E-01 |
| Caucasian-vs-Asian |
9.480600E-01 |
| AfricanAmerican-vs-Asian |
8.445400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.56790000002982E-06 |
| Normal-vs-Female |
4.06849999999848E-05 |
| Male-vs-Female |
1.739030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.825100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.79605999999222E-05 |
| Normal-vs-Age(61-80Yrs) |
5.06789999965562E-07 |
| Normal-vs-Age(81-100Yrs) |
1.652180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.679700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.817990E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.384000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.473600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.138200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.834600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.563000E-04 |
| Classical-VS-Follicular |
1.190430E-01 |
| Classical-VS-Other |
5.558400E-01 |
| Classical-VS-Normal |
8.08460000000233E-05 |
| Tall-VS-Follicular |
5.887800E-01 |
| Tall-VS-Other |
5.569600E-01 |
| Tall-VS-Normal |
8.84520000021816E-07 |
| Follicular-VS-Other |
9.530400E-01 |
| Follicular-VS-Normal |
1.68598999999992E-05 |
| Other-VS-Normal |
1.558620E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.32539999997405E-06 |
| Normal-vs-N1 |
2.40229999999286E-05 |
| N0-vs-N1 |
2.349600E-01 |
|
|
